Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer.

Identifying and addressing the toxicity of checkpoint inhibitors in lung cancer. Clin Adv Hematol Oncol. 2016 Mar;14(3):165-167 Authors: Brahmer JR PMID: 27058029 [PubMed - as supplied by publisher]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research